Podcast appearances and mentions of albert garcia romeu

In this episode Dr. Gillian Beauchamp sits down with Dr. Albert Garcia Romeu to discuss the history of psychedelic use, current treatment protocols and research on using psychedelics to support recovery from substance use disorders. 

It's effective against depression, can help you stop smoking, even ease end-of-life distress. It's non-addictive, naturally occurring, and has been used for thousands of years -- but you can't have it. It's psilocybin, the compound that creates the "magic" in dozens of species of mushrooms. Johns Hopkins researcher Albert Garcia-Romeu, Ph.D. knows just how magical it is. He's conducting research on psilocybin's therapeutic value for everything from persistent Lyme disease to a range of mental health conditions. Find out what this psychedelic drug can do, and why it got such a bad reputation. Plus... revisiting Timothy Leary's rise and fall as he turned on, tuned out, and dropped out. For more information, transcripts, and all episodes, please visit https://thisisyourbrain.com For more about Weill Cornell Medicine Neurological Surgery, please visit https://neurosurgery.weillcornell.org 

It's effective against depression, can help you stop smoking, even ease end-of-life distress. It's non-addictive, naturally occurring, and has been used for thousands of years -- but you can't have it. It's psilocybin, the compound that creates the "magic" in dozens of species of mushrooms. Johns Hopkins researcher Albert Garcia-Romeu, Ph.D. knows just how magical it is.

@WCSU is back! Paul is joined by Dr. Albert Garcia-Romeu from the Johns Hopkins Center for Psychedelic and Consciousness Research to preview the keynote address for this year's Western Research Day on May 3, 2024

I couldn't help asking question about the field of psychedelics research beyond our last conversation. He's a professional at the top of the field and well-connected. I started by asking him about comedy and psychedelics, after reading a funny piece in The Onion about it. He responded seriously, after all, there's a lot of humor in psychedelics.Then he shared about the growing communities of professionals and non-professionals. We both talked about trends in tourism, psychedelics, and sustainability. A lot of people are flying around and doing other things that lower Earth's ability to sustain life in the name of helping. They're achieving the opposite of what the marketers sold them on. Others are homogenizing and assimilating cultures in the name of promoting and protecting them.We talked about his experiences with his commitment from last time, including appreciating nature where we are, not feeling we have to drive or travel to find it. Hosted on Acast. See acast.com/privacy for more information.

Here's the episode you voted as our best drug episode: Magic Mushrooms! People are saying that shrooms cured their depression and anxiety. But is this for real? How could taking a trip on psychedelics fix your brain? Today, magic mushrooms ditch their tie dye for a lab coat as we go on a magical journey into the science. We talk to clinical psychologists Dr. Alan Davis and Dr. Albert Garcia-Romeu, and neuropsychologist Dr. Katrin Preller. Here's a link to our transcript: https://bit.ly/SVFavDrugsEp This episode does deal with depression. Here are some crisis hotlines:  United States: US National Suicide Prevention Lifeline  988 (Online chat available); US Crisis Text Line Text “GO” to 741741 Australia: Lifeline 13 11 14 (Online chat available) Canada: Canadian Association for Suicide Prevention (See link for phone numbers listed by province) United Kingdom: Samaritans 116 123 (UK and ROI) (Online chat available) Full list of international hotlines here  This episode was produced by Meryl Horn and Michelle Dang with help from Wendy Zukerman, Nick DelRose, Rose Rimler and Hannah Harris Green. We're edited by Blythe Terrell. Fact checking by Diane Kelly. Mix and sound design of this episode was by Bobby Lord. Mix and sound design of our original episode was by Peter Leonard. Music written by Peter Leonard, Marcus Bagala, Emma Munger, and Bobby Lord. A huge thanks to all the researchers we got in touch with for this episode, including Prof. David Nichols, Dr. James Rucker, Prof. Bryan Roth, Dr. Erika Dyck, Dr. Daniel Wacker, Mary Cosimano, Dr. Fred Barrett, Dr. Natalie Gukasyan, Dr. Jeff Guss, Dr. Suresh Muthukumaraswamy. Prof. Harriet de Wit, Dr. Nadia Hutten, Dr. Vince Polito, Dr. Kim Kuypers and Dr. Matt Kasson. Thanks to all the clinical trial participants and ‘psychonauts' who spoke to us. And special thanks to Lexi Krupp, Zukerman family and Joseph Lavelle Wilson. Science Vs is a Spotify Studios Original. Listen for free on Spotify or wherever you get your podcasts. Follow us and tap the bell for episode notifications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Psychedelic drugs like psilocybin, or magic mushrooms, have been used throughout human history. But it's only in the last few decades that researchers have been examining them as a potential tool for treating an array of mental health issues. Albert Garcia-Romeu, a Johns Hopkins behavioral pharmacology researcher, talks with Stephanie Desmon about his research with psilocybin, the promising outcomes, and how approval and proper regulation could lead to a whole class of psychedelic drugs used responsibly as treatment for mental health disorders.

Magic mushrooms – or psilocybin – may be associated with tripping hippies and Woodstock, but they are now being studied as new treatments for depression and neurodegenerative diseases like Alzheimer's. Is this Age of Aquarius medicine or something that could really work? Plus, the centuries-long use of psychedelics by indigenous peoples, and a discovery in California's Pinwheel Cave offers new clues about the relationship between hallucinogens and cave art. Guests: Merlin Sheldrake - Biologist and the author of Entangled Life: How Fungi Make our Worlds, Change our Minds and Shape our Futures. Albert Garcia-Romeu - Assistant professor in the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine David Wayne Robinson - Archeologist in the School of Forensic and Applied Sciences, University of Central Lancashire, U.K. Sandra Hernandez - Tejon Indian Tribe spokesperson Originally aired December 7, 2020 Featuring music by Dewey Dellay and Jun Miyake Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support!   Learn more about your ad choices. Visit megaphone.fm/adchoices

See omnystudio.com/listener for privacy information.

Regular listeners know I've been asking people what the environment means to them as part of the Spodek Method. Many people respond with touching answers that I would call something close to life-altering. Maybe more like life-guiding, life-enhancing, or giving meaning and purpose.I've heard of increasing research into psychedelics recently. Reading reports of people who took psylocibin in clinical settings with guides for the experience, I was struck by how similar their effects to those of quintessential moments in the environment. Both talked about oneness, awe, humility, understanding, feeling understood, connectedness, and similar things, though, of course, each experience was unique. Many said that the effects of their experiences lasted sometimes years, potentially permanently. Many could stop addictions overnight without relapsing. Some improved relationships with loved ones.I hypothesized that some of the experience of psychedelics might have been a regular part of the lives of our ancestors who lived in the 250,000 years or so before civilization, as well as those who live outside it today. Might the drugs just be achieving something remedial that had long been part of our lives?Might we who live in human-built environments be missing deeply meaningful parts of our lives that were regular for nearly all our ancestors? Might that lack be contributing to our not knowing what we're missing when we capitulate, abdicate, and resign to choose comfort and convenience over alleviating suffering and caring for our neighbors?I emailed with Roland Griffiths, the head of the Johns Hopkins Center for Psychedelic Research, which I understand to be the premier research center in the field. He put me in touch with Albert. I couldn't wait to compare the effects and potential of psychedelics with the effects and potential of simply spending time in nature.Albert Garcia-Romeu's page at the Johns Hopkins Center for Psychedelic and Consciousness Research Hosted on Acast. See acast.com/privacy for more information.

In just a few years, psychedelics have gone from being a symbol of the 1960s counterculture to being touted as highly promising mental health treatments. Dr. Albert Garcia-Romeu, PhD, of Johns Hopkins University, talks about whether the research backs up the hype; the state of psychedelic therapy research for PTSD, depression, addiction and other mental health disorders; how psychedelics work in the brain and mind; and whether psychedelic treatments are likely to be approved in the U.S. any time soon. Please help us know more about you and what you would like to hear more of from Speaking of Psychology by filling out our 2023 Audience Survey. For transcripts, links and more information, please visit the Speaking of Psychology Homepage.

Today, we talk about psilocybin and Alzheimer's with Albert Garcia-Romeu, PhD, a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine. Dr. Albert Garcia-Romeu is a also a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. Dr. Garcia's current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying neurobiological mechanisms, and the role of spirituality in mental health and addiction. ◘ Related Links Johns Hopkins University Center for Psychedelic and Consciousness Research bit.ly/3DQHcwM Psilocybin & Alzheimer's Clinical Trial Participant Screening Form bit.ly/3XbvWSN Video: Psilocybin for Depression in early Alzheimer's Disease Clinical Trial at John Hopkins bit.ly/40DFitf Dr. Albert Garcia-Romeu bio bit.ly/3I2GWw0 ◘ Transcript bit.ly/3RZqgu3 ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

The recent surge of psychedelic research has sparked a growing interest in psychedelic-assisted therapy using psilocybin to treat various mental health conditions including addiction. In this episode, Trauma Report writer Michelle Kim discusses this approach in detail with Dr. Albert Garcia-Romeu from the Johns Hopkins University School of Medicine at the Center for Psychedelic & Consciousness Research. Dr. Garcia-Romeu works in the Behavioral Pharmacology Research Unit at the Department of Psychiatry and Behavioral Sciences, and is also a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging. Tune into our podcast to learn more about the therapeutic potential of psilocybin for addiction treatment.

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John's Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John's Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Albert Garcia-Romeu, Ph.D. Assistant Professor of Behavioral Pharmacology Research Unit of the Department of Psychiatry and Behavioral Sciences with Johns Hopkins University School of Medicine today on Psychedelic Radio with Christina Thomas, president and founder of MY Self Wellness, and Charles Patti, brand ambassador of MY Self Wellness only on The Cannabis Radio.Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch, where he studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction.

Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction.https://hopkinspsychedelic.org/garcia-romeuhttps://hopkinspsychedelic.org

There's been an explosion of interest in psychedelics over the last 10 years, and phrases like “psychedelic-assisted therapy” have gone from the relative fringes of the mental health conversation to bursting into the mainstream. Alongside a great deal of hype is a growing body of research revealing the potential of substances like psilocybin and MDMA as novel treatments for depression, addiction, and PTSD. On today's episode of Being Well, Forrest is joined by Dr. Albert Garcia-Romeu from the Johns Hopkins Center for Psychedelic and Consciousness Research. They explore the history and current state of psychedelic research, their subjective effects, the necessity of the “trip,” how psychedelics work in the brain, why researchers are so interested in these substances, and what a psychedelic-assisted therapy session looks like.About Our Guest: Dr. Garcia-Romeu is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction.Watch the Episode: Prefer watching video? You can watch this episode on YouTube.Key Topics:0:00: Introduction1:55: Dr. Garcia-Romeu's background3:00: What substances have been the focus of research?8:10: The history of psychedelics11:15: Usefulness and subjective effects of classical psychedelics (LSD/Psilocybin)17:35: Ego loss or “ego-death” and the role of spirituality in mental health21:40: What is happening neurologically with Psilocybin? 27:55: Psychedelics may be the best current treatment option for some conditions35:05: How close is the research to proving efficacy?38:05: The relative safety of psychedelics41:00: What does a psychedelic-assisted therapy session look like?47:00: Self-guidance in a session49:50: Duration of treatment, financial and legal access54:00: Using psychedelics for personal growth, spiritual practice, and even recreation58:00: Where is the field going?59:25: RecapSupport the Podcast: We're now on Patreon! If you'd like to support the podcast, follow this link.Sponsors:Bombas designed their socks, shirts, and underwear to be the clothes you can't wait to put on every day. Visit bombas.com/beingwell and use code beingwell for 20% off. Join over a million people using BetterHelp, the world's largest online counseling platform. Visit betterhelp.com/beingwell for 10% off your first month!Want to sleep better? Try the Calm app! Visit calm.com/beingwell for 40% off a premium subscription.Ready to shake up your protein Ritual? Being Well listeners get 10% off during your first 3 months at ritual.com/WELL.Connect with the show:Subscribe on iTunesFollow Forrest on YouTubeFollow us on InstagramFollow Forrest on InstagramFollow Rick on FacebookFollow Forrest on FacebookVisit Forrest's website

Tim Hayward takes a journey into the world of fungi. There's a global wave of interest in the potential uses of fungi right now - and businesses are catching on and playing their part. Tim starts at the Fungarium in Kew Gardens, the world's biggest collection of dried fungal specimens, guided by collections curator Lee Davies. He then heads to a forest in Finland, where chief executive Eric Puro and lab manager Joette Crosier walk him through the setup at Kääpä Biotech - one of a new breed of fungally-focussed companies with big ambitions rooted in a passion for mushrooms and mycelium. Then he talks with Albert Garcia-Romeu, an assistant professor of psychiatry and behavioural sciences at the Johns Hopkins University School of Medicine. Albert is part of a research team looking at the fungally-derived compound psilocybin - about which there's a huge amount of interest relating to its therapeutic potential. Presenter: Tim Hayward Producer : Richard Ward. Image: Shiitake (Lentinula edodes) mushrooms being cultivated at Kääpä Mushrooms, Karjalohja, Finland. Used with permission. Tim's three-part series about fungi, ‘Fungi: The New Frontier', is available now on BBC Sounds.

Psychedelics are mind-altering drugs. What does it mean to have your mind-altered? What is actually going on in the brain when we set off on a psychedelic trip. Johns Hopkins University researcher Albert Garcia-Romeu talks about his research into psychedelics and reviews sciences current understanding about how psychedelics improve mood, limit depression, alter our states of mind and give us a feeling of transcendent insight. 

Albert Garcia-Romeu does research on psychedelics at Johns Hopkins University. In this first part of our discussion I asked Al why older adults should be interested in psychedelic research. How could psychedelics help us to enjoy a more successful longevity?  We also delve into the subjective experience of a psychedelic trip. What do people taking psychedelics in a clinical setting report feeling, and how what kind of benefits does the trip provide? 

In this episode, Nate interviews Dr. Albert Garcia Romeu of Johns Hopkins Center for Psychedelic and Consciousness Research. First, we discuss the state of diversity within psychedelic research, both in terms of the research subjects and the researchers themselves. We pointed out how this may be particularly problematic in psychedelic science, as it tests many deep assumptions about culture and context that a homogenous group (such as monocultural White, Educated, Industrialized, Rich, Democratic- WEIRD- researchers) might not take broad enough perspectives on. Additionally we discuss the cool study on psilocybin that has led to a big NIH grant, and how psilocybin may be able to help people struggling to quit smoking.

On today's episode, rapper 24kGoldn joins host Mathias Rosenzweig to learn about the ins and outs of psychedelics. Why do psychedelics even exist in nature? Why did the US government slip LSD to unsuspecting American citizens during the Cold War? And what was it like for 24kGoldn to do shrooms with his mom? We asked a smart person: Dr. Albert Garcia-Romeu, a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse's Intramural Neuroimaging Research Branch. V Wanna Know is produced and edited by Ryan Killian Krause.

Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine where he studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness, and their underlying neurobiological and psychological mechanisms.

In this episode Cody talks about how his documentary called Plants Vs. Pills transformed to become The Awakened Underground.  Cody Also interviews Dr. Albert Garcia-Romeu from Johns Hopkins.   Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He received his doctorate in Psychology in 2012 from Sofia University in Palo Alto, CA, where he studied self-transcendence and meditation, and their relationship to mental health. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying neurobiological mechanisms, real-world drug use patterns and impacts on public health, the role of spirituality in mental health and addiction, and use of qualitative and mixed methodologies towards investigating these areas. Time stamps:   0:06 - Disclaimer 1:50 - Cody tells the story of how Plants Vs. Pills became The Awakened Underground 15:39 - Intro: Dr. Albert Garcia-Romeu 16:29 - Interview with Dr. Garcia-Romeu 20:38 - The evolution of anti-depressants 25:45 - The inherent narrative that comes with the term "neuro-chemical imbalance"  35:30 - Yale research involving mice and psilocybin  37:25 - psychedelic therapies for pain tolerance and relief 42:05 - Psychedelics pointing us towards a sense of wholeness, healing as a whole and what that means for the "cosmic community" 51:50 - passing on trauma through genetic mechanisms and generational trauma 1:00:16 - Conceptions surrounding religion and spirituality  1:06:32 - Connecting to ourselves and to one another, and some risks and cautions regarding psychedelic medicines 1:09:37 - the medical model and other ways of working with psychedelic medicines 1:10:47 - the importance of having fun, and coming together to have a communal human experience  1:13:18 - The modern fire ceremony and different types of ecstatic ritual 1:17:58 - Respect for indigenous cultures and the importance of an equitable movement 1:22:57 - Capitalism and a health care system predicated on the for-profit model  1:42:00 - Psilocybin in incarceration settings for rehabilitation purposes 1:43:37 - Thinking in different ways about society, illness and psychedelics  1:44:29 - What big medicines have healing applications in society?      See omnystudio.com/listener for privacy information.

It's effective against depression, can help you stop smoking, even ease end-of-life distress. It's non-addictive, naturally occurring, and has been used for thousands of years -- but you can't have it. It's psilocybin, the compound that creates the "magic" in dozens of species of mushrooms. Johns Hopkins researcher Albert Garcia-Romeu, Ph.D. knows just how magical it is. He's conducting research on psilocybin's therapeutic value for everything from persistent Lyme disease to a range of mental health conditions. Find out what this psychedelic drug can do, and why it got such a bad reputation. Plus... revisiting Timothy Leary's rise and fall as he turned on, tuned out, and dropped out. https://hopkinspsychedelic.org/garcia-romeu   

REAIR: Original Date May 5, 2021Why are psychedelics still so taboo? Can they really be used to improve our mental health? Is there a place for psychedelics in the fitness world?We're sitting down with Albert Garcia-Romeu, Ph.D., a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine, to answer these questions and more.Dr. Garcia-Romeu studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction and PTSD. He tells Sean the history of psychedelics, why they were banned in the first place, and how he hopes they'll be integrated into our every day life.You can find more about Dr. Albert Garcia Romeu here.*Find your next Tough Mudder event here: http://bit.ly/35q39iHCan't get enough of Mudder Nation? Check out our blog: http://bit.ly/3iTuG4cDiscover the 2021 Tough Mudder Training Guides: http://bit.ly/3iP4pUGDon't forget to subscribe to the 'No Excuses' Podcast and follow Tough Mudder on social media:Instagram: @tough_mudderFacebook: @toughmudderTwitter: @toughmudderSubscribe on SpotifySubscribe on Apple*Welcome to the ‘No Excuses' Podcast by Tough Mudder. A place where Mudder Nation can come together to hear deep-dive conversations with fitness + health experts, everyday athletes and community members. Join us every Wednesday as we uncover the stories and inspiration that make this community so great. Hosted by Sean Corvelle.*Host: Sean CorvelleSenior Producer: Johanna OvsenekPodcast Editor: Laken Watters, Gillian George© 2021 Spartan

Magic mushrooms – or psilocybin - may be associated with tripping hippies and Woodstock, but they are now being studied as new treatments for depression and neurodegenerative diseases like Alzheimer's. Is this Age of Aquarius medicine or something that could really work? Plus, the centuries-long use of psychedelics by indigenous peoples, and a discovery in California's Pinwheel Cave offers new clues about the relationship between hallucinogens and cave art. Guests: Merlin Sheldrake - Biologist and the author of Entangled Life: How Fungi Make our Worlds, Change our Minds and Shape our Futures. Albert Garcia-Romeu - Assistant professor in the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine David Wayne Robinson - Archeologist in the School of Forensic and Applied Sciences, University of Central Lancashire, U.K. Sandra Hernandez - Tejon Indian Tribe spokesperson Originally aired December 7, 2020 Big Picture Science is part of the Airwave Media podcast network. Please contact sales@advertisecast.com to inquire about advertising on Big Picture Science.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Podcast: The Consciousness Podcast (LS 42 · TOP 1.5% what is this?)Episode: Episode 42: Psilocybin, Addiction and Consciousness with Dr. Garcia-RomeuPub date: 2020-11-20In this episode, I had the honor of speaking with Dr. Albert Garcia-Romeu, Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins and a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch, where he studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction. We discussed his work with psilocybin, what it means to be addicted, and what insight his work has given him into the mystery of consciousness. So, please enjoy this episode, with Dr. Garcia-Romeu. We discussed: You did some work in treating addiction to tobacco with the aid of psilocybin. Can you tell us a little about that study? Matt JohnsonHow do you think psilocybin actually worked in creating those amazing results?What is the key to breaking an addiction? Ego dissolution; mysticalOther psyches and addiction: ibogaine/opioids?Cognitive behavioral therapy; Counselling; 3 monthsDoes psilocybin help with addictions of all kinds? Alcohol? Gambling? Etc.?Can you tell us about dosing psilocybin for treatment of addiction?Is it just a pill the patient takes, or is there more to it? See aboveWhat other long-term effects did you notice in your patients? Spirituality? Mystical effects? Other changes?Any relationship between dose and mystical effects? Challenging experiences and dose, i.e. a bad trip?Any comment on the relationship between the mystical experience and one's consciousness?How is psilocybin metabolized in the human body? Did you administer doses based on body weight?[how do these measurements relate to a single mushroom?]What about other psychedelics, such as LSD, Ayahuasca? You've recently published some papers on Kratom? “Kratom” — how do you pronounce that one (krat-um)? Do these also help with addiction?What insights do psychedelics give, through altered states of consciousness, into their underlying neurobiological mechanisms?What are the neurobiological mechanisms of consciousness?Let's step out into the philosophical aspect of consciousness, given your insights into non-ordinary states of consciousness. What are your thoughts on trying to answer the Hard Question of Consciousness — why the phenomenal experience of, say, seeing a red apple?Is consciousness a function of the brain, of our hardware? Mind/body duality?What else? What haven't I asked? Center for Psych and Consciousness Johns Hopkins; What's next for you, what are you excited about?Hopkinspsychedelic.orgUnlimited Sciences collaboration; real world psilocybin use; 3,000 enrolled; The post Episode 42: Psilocybin, Addiction and Consciousness with Dr. Garcia-Romeu appeared first on The Consciousness Podcast.The podcast and artwork embedded on this page are from The Consciousness Podcast, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

Today, we're visited by Albert Garcia-Romeu, one of the key members of the Center for Psychedelic and Consciousness Research at John Hopkins University. Coming from Miami, Albert grew up with a thirst for knowledge and a boundless intellectual capacity to improve. He read everything he could, and developed love for poetry and philosophy from a very early age. Those intellectual pursuits took him through a college career at Tulane University before working for the Forest Service for a number of years. Venturing out into the wilderness often, Albert had meditative experiences with nature that profoundly moved him. Albert began to try and study what he called Transcendent Experiences in order to merge his love of psychology and philosophy with this moving experience he had with nature. That quest took him to California, where he started to conduct his research on these seemingly mystical events. From there, he followed his results and began to work in the realm of psychedelic drugs which had him move across the country, change his perspective, and set him on a path into the unknown world of psychedelic therapy. Links From the Episode Michael Pollan-How to Change Your Mind: https://michaelpollan.com/ Ken Wilber: https://integrallife.com/who-is-ken-wilber/ Behavioral Pharmacology Research Unit: https://www.hopkinsmedicine.org/psychiatry/research/BPRU/ Links to presentations by Albert: https://hopkinspsychedelic.org/garcia-romeu Katherine MacLean: https://www.katherinemaclean.org/ --- Support this podcast: https://anchor.fm/finding-founders/support

Why are psychedelics still so taboo? Can they really be used to improve our mental health? Is there a place for psychedelics in the fitness world?We're sitting down with Albert Garcia-Romeu, Ph.D., a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine, to answer these questions and more. Dr. Garcia-Romeu studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction and PTSD. He tells Sean the history of psychedelics, why they were banned in the first place, and how he hopes they'll be integrated into our every day life.You can find more about Dr. Albert Garcia Romeu here.*Find your next Tough Mudder event here: http://bit.ly/35q39iHCan't get enough of Mudder Nation? Check out our blog: http://bit.ly/3iTuG4cDiscover the 2021 Tough Mudder Training Guides: http://bit.ly/3iP4pUGDon't forget to subscribe to the 'No Excuses' Podcast and follow Tough Mudder on social media:Instagram: @tough_mudderFacebook: @toughmudderTwitter: @toughmudderSubscribe on SpotifySubscribe on Apple*Welcome to the ‘No Excuses' Podcast by Tough Mudder. A place where Mudder Nation can come together to hear deep-dive conversations with fitness + health experts, everyday athletes and community members. Join us every Wednesday as we uncover the stories and inspiration that make this community so great. Hosted by Sean Corvelle.*Host: Sean CorvelleSenior Producer: Johanna OvsenekPodcast Editor: Laken Watters, Ryan Warner© 2021 Spartan

Long dismissed as hallucinations, the beings that people see on DMT are attracting more and more scientific interest. These beings, and the ways that they behave, are strikingly similar to those encountered by "alien" abductees, and even biblical prophets. Support us on Patreon: Patreon.com/user?u=3375417 Donate on Paypal: ThinkAnomalous.com/support.html Watch video version: YouTube.com/ThinkAnomalous Website: ThinkAnomalous.com Full sources and transcript: ThinkAnomalous.com/DMT.html Facebook: Facebook.com/ThinkAnomalous Twitter: Twitter.com/Think_Anomalous Instagram: Instagram.com/Think.Anomalous Think Anomalous is created by Jason Charbonneau. Research by Clark Murphy. Music by Josh Chamberland. Sound design by Will Mountain and Josh Chamberland. Illustration by V.R. Laurence (VRLaurence.com). Main Sources: Devereux, Paul. The Long Trip: A Prehistory of Psychedelia. New York, NY, USA: Penguin Group, 1997. Frecska, Ede, Petra Bokor, and Michael Winkelman,. “The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization.” Frontiers in Pharmacology 7, no. 35 (2016): 1-17. DOI: 10.3389/fphar.2016.00035. Johnson, Matthew W., Albert Garcia-Romeu, and Roland R. Griffiths. “Long-term Follow-up of Psilocybin-facilitated Smoking Cessation.” The American Journal of Drug and Alcohol Abuse 43, no. 1 (2017): 55-60, doi:10.3109/00952990.2016.1170135. Luke, David. “Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology.” Journal of the American Society for Psychical Research 75, no. 902 (January 2011): 26-42. Luke, David, Rory Spowers, and Anton Bilton, eds. DMT Dialogues: Encounters with the Divine Molecule. Rochester, Vermont, USA: Park street Press, 2018. Luke, David. “Understanding DMT with David Luke.” New Thinking Allowed with Jeffrey Mishlove. November 5, 2018. YouTube video, 33:31. https://youtu.be/rCdLO-UP8No. McKenna, Terence. The Archaic Revival. New York, NY, USA: HarperOne, 1991. McKenna, Terence, and Dennis McKenna. The Invisible Landscape: Mind, Hallucinogens, and the I Ching. San Francisco, California, USA: HarperCollins, (1975) 1993. National Center for Biotechnology Information. PubChem. Samorini, Giorgio. “The oldest Representations of Hallucinogenic Mushrooms in the World (Sahara Desert, 9000-7000 B.P.).” Integration, no. 2 & 3 (1992): 69-78. Schultes, Richard Evans, Albert Hofmann, and Christian Rätsch. Plants of the Gods. Rochester, Vermont, USA: Healing Arts Press, (1992) 2001. St. John, Graham. Mystery School in Hyperspace: A Cultural History of DMT. North Atlantic Books, 2015. Strassman, Rick. DMT and the Soul of Prophecy: A New Science of Spiritual Revelation in the Hebrew Bible. Rochester, Vermont, USA, Toronto, Canada: Park Street Press, 2014. Strassman, Rick. DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences. Rochester, Vermont: Park Street Press, 2001. This podcast uses sound effects downloaded from http://stockmusic.com.

Dr. Albert Garcia-Romeu discusses his research at Johns Hopkins Medical Center involving Psilocybin and its potential in treating multiple mental health disorders. We discuss the state of the field and potential future directions. Research Assistants Sam Nidorf and Austin Asa guest co-host.

Magic mushrooms – or psilocybin - may be associated with tripping hippies and Woodstock, but they are now being studied as new treatments for depression and neurodegenerative diseases like Alzheimer's. Is this Age of Aquarius medicine or something that could really work? Plus, the centuries-long use of psychedelics by indigenous peoples, and a discovery in California's Pinwheel Cave offers new clues about the relationship between hallucinogens and cave art. Guests: Merlin Sheldrake - Biologist and the author of Entangled Life: How Fungi Make our Worlds, Change our Minds and Shape our Futures. Albert Garcia-Romeu - Assistant professor in the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine David Wayne Robinson - Archeologist in the School of Forensic and Applied Sciences, University of Central Lancashire, U.K. Sandra Hernandez - Tejon Indian Tribe spokesperson Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's show features our first guest from Johns Hopkins University, Dr. Albert Garcia-Romeu. We discuss the history of clinical research on psilocybin, its implications, and its bright future for healing. We also discuss the possibility of treating Alzheimer's and dementia with psilocybin. Dr. Garcia-Romeu gives us an in-depth perspective on the execution of this important research, and hopefully inspires others to fuel its progression..Dr. Albert Garcia-Romeu is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Research Program. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He received his doctorate in Psychology in 2012 from the Institute of Transpersonal Psychology in Palo Alto, CA, where he studied self-transcendence and meditation, and their relationship to mental health. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying psychological mechanisms. He additionally studies real-world drug use patterns and impacts on public health, and the role of spirituality in mental health and addiction.